Zobrazeno 1 - 10
of 12
pro vyhledávání: '"Yilian Yang"'
Autor:
Yi Miao, Yeqin Sha, Yi Xia, Shuchao Qin, Rui Jiang, Luomengjia Dai, Hui Shen, Tonglu Qiu, Wei Wu, Jingyan Qiu, Yilian Yang, Chongyang Ding, Yujie Wu, Lei Fan, Wei Xu, Jianyong Li, Huayuan Zhu
Publikováno v:
Blood Cancer Journal, Vol 13, Iss 1, Pp 1-4 (2023)
Externí odkaz:
https://doaj.org/article/4b8098f2b3474261a50e12260d489857
Autor:
Hua-Yuan ZHU, Yi Miao, Yeqin Sha, Yi Xia, Shu-Chao Qin, Rui Jiang, Luomengjia Dai, Hui Shen, Tonglu Qiu, Wei Wu, Jingyan Qiu, Yilian Yang, Chong-Yang Ding, Yujie Wu, Lei Fan, Wei Xu, Jianyong Li
Time-limited treatment strategies in first line treatment of chronic lymphocytic leukemia/small lymphocytic leukemia (CLL/SLL) were comprehensively explored. Thirty-four previously untreated, young fit CLL/SLL patients who initiated iFCR regimen betw
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::bd3188f427f6b197ba54f87aa12adcd5
https://doi.org/10.21203/rs.3.rs-2888639/v1
https://doi.org/10.21203/rs.3.rs-2888639/v1
Autor:
Yunqi Liu, Jiapan Wang, Xiuye Zhao, Wen Li, Yaohua Liu, Xingda Li, Dan Zhao, Jie Yu, Bing Shao, Zhendong Li, Jia Wang, Yilian Yang, Yan Hao, Yuting Wu, Ye Yuan, Zhimin Du
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a6fbde37e2551426fa24281001eb6c4f
https://doi.org/10.2139/ssrn.4391580
https://doi.org/10.2139/ssrn.4391580
Autor:
Jie Yu, Xiuye Zhao, Xiuqing Yan, Wen Li, Yunqi Liu, Jiapan Wang, Jia Wang, Yilian Yang, Yan Hao, Zhen Liang, Yiping Tao, Ye Yuan, Zhimin Du
Publikováno v:
Phytomedicine. 114:154793
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8997aa198d356662157475678020aa26
https://doi.org/10.1016/j.phymed.2023.154793
https://doi.org/10.1016/j.phymed.2023.154793
Publikováno v:
Bone Marrow Transplantation. 55:1677-1680
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8fc3211c1f9afc159cc4b5520822edbc
https://doi.org/10.1038/s41409-019-0736-5
https://doi.org/10.1038/s41409-019-0736-5
Autor:
Sanmei Wang, Jianyong Li, Michael Schmitt, Maria Luisa Schubert, Lei Fan, Yu Zhu, Yilian Yang
Publikováno v:
Blood. 138:4792-4792
Purpose: Chimeric antigen receptor T (CAR-T) cell therapy has demonstrated impressive responses in refractory and relapsed acute lymphoblastic leukemia (ALL) and non-hodgkin's lymphoma (NHL), however, the outcome among chronic lymphoblastic leukemia
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::16a8739a79313e3fe9d88d2f11b7f9df
https://doi.org/10.1182/blood-2021-150661
https://doi.org/10.1182/blood-2021-150661
Autor:
Wei Xu, Wei Wu, Hua-Yuan Zhu, Rui Jiang, Jingyan Qiu, Li Wang, Hui Shen, Chen Peng, Chuanbing Shi, Lei Fan, Yilian Yang, Rui-Ze Chen, Chongyang Ding, Jianyong Li
Publikováno v:
Blood. 138:4695-4695
Background: To evaluate the efficacy and safety of venetoclax, rituximab plus dose-adjusted etoposide, prednisone, vincristine, cyclophosphamide, and doxorubicin (VR-DA-EPOCH) in Richter's syndrome (RS), we conducted a single-arm, retrospective, obse
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ffea2f459c653d4c05e1d37701cf8b4d
https://doi.org/10.1182/blood-2021-152483
https://doi.org/10.1182/blood-2021-152483
Autor:
Wei Xu, Hongling Mi, Ze Jin, Li Wang, Chuanbing Shi, Lei Fan, Chen Peng, Jianyong Li, Yeqin Sha, Chongyang Ding, Yilian Yang, Zhen Wang, Wei Wu, Jingyan Qiu, Hua-Yuan Zhu, Rui-Ze Chen
Publikováno v:
Blood. 138:4697-4697
Introduction To evaluate the safety and efficacy of BTK inhibitor ibrutinib or zanubrutinib plus bendamustine and rituximab (iBR or zBR) as the initial treatment for chronic lymphocytic leukemia (CLL)/ small lymphocytic leukemia (SLL) patients, we co
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::86339c9f27d0411db53d10aee48bd501
https://doi.org/10.1182/blood-2021-152147
https://doi.org/10.1182/blood-2021-152147
Autor:
Yilian Yang, Chongyang Ding, Hongling Mi, Hua-Yuan Zhu, Yeqin Sha, Jianyong Li, Jingyan Qiu, Rui-Ze Chen, Chun Qiao, Lei Fan, Li Wang, Yu-Jie Wu, Hui Shen, Wei Xu
Publikováno v:
Blood. 136:29-30
Purpose: To evaluate the safety and efficacy of ibrutinib plus fludarabine, cyclophosphamide, and rituximab (iFCR) as the treatment for chronic lymphocytic leukemia (CLL)/ small lymphocytic leukemia (SLL) patients, we conducted time-limited, minimal
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::08b5aae272076de049036f6a4ecd1ac0
https://doi.org/10.1182/blood-2020-141747
https://doi.org/10.1182/blood-2020-141747
Autor:
Hui-Hui Wang, Jiakai Liu, Zhenming Zhang, Dongdong Qiu, Yilian Yang, Wu Ma, Lijuan Zhu, Jiatong Liu, Jinglan Liu
Publikováno v:
Atmospheric Environment. 125:178-187
The dry deposition of particular matters from atmosphere to ecosystems is an undesirable consequence of this pollution while the deposition process is also influenced by different land use types. In current study, concentration of fine particles, coa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0f6ae0819628449d5361b0089c60873
https://doi.org/10.1016/j.atmosenv.2015.11.023
https://doi.org/10.1016/j.atmosenv.2015.11.023